SALIVARY GLAND CARCINOMA
Clinical trials for SALIVARY GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SALIVARY GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for SALIVARY GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug duo takes on rare head and neck tumors
Disease control Recruiting nowThis trial investigates whether combining two drugs, camrelizumab and famitinib, can help people with rare head and neck cancers that have spread or cannot be removed by surgery. The study includes four types of these cancers and aims to see how safe and effective the treatment i…
Matched conditions: SALIVARY GLAND CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New targeted chemo aims to hit tumors harder, spare healthy tissue
Disease control Recruiting nowThis early-phase trial tests AVA6000, a chemotherapy drug that is designed to activate only in tumors, potentially reducing side effects. About 158 adults with advanced solid tumors (like breast, ovarian, or salivary gland cancer) will receive the drug intravenously. The main goa…
Matched conditions: SALIVARY GLAND CARCINOMA
Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New precision therapy trial aims to match salivary gland cancer patients with the right drug
Disease control Recruiting nowThis study tests whether giving targeted therapy or chemotherapy based on specific markers (HER2, NTRK, AR, TROP-2) found in a patient's tumor can shrink or control salivary gland cancer. About 39 adults with advanced or recurrent cancer will receive a treatment matched to their …
Matched conditions: SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Peking Union Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy targets rare salivary gland cancer
Disease control Recruiting nowThis study tests a combination of hormone therapy (goserelin) and an immunotherapy drug (pembrolizumab) in 20 people with advanced salivary gland cancer that cannot be removed by surgery or radiation. The goal is to see if the treatment shrinks tumors or slows the disease. Partic…
Matched conditions: SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Manish Patel • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Common pain gel could shield cancer patients from radiation burns
Prevention Recruiting nowThis study tests whether a gel containing diclofenac, a common anti-inflammatory drug, can prevent severe skin irritation caused by radiation therapy. About 156 adults with head/neck or breast cancer will apply the gel or a placebo to the treated skin three times daily during the…
Matched conditions: SALIVARY GLAND CARCINOMA
Phase: NA • Sponsor: The Second Affiliated Hospital of Hainan Medical University • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Scientists hunt for immune clues in rare salivary gland cancers
Knowledge-focused Recruiting nowThis study is for 300 people with salivary gland tumors (both cancerous and non-cancerous) to learn how the immune system reacts to these rare cancers. Researchers will collect tumor tissue and blood samples before and after treatment to find immune markers that might predict how…
Matched conditions: SALIVARY GLAND CARCINOMA
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC